title: Effect of oseltamivir carboxylate consumption on emergence of drug-resistant H5N2 avian influenza virus in Mallard ducks.
abstract: Oseltamivir carboxylate (OC) has been detected in environmental waters at various levels during recent influenza seasons in humans, reflecting levels of usage and stability of this drug. In consideration of the role of waterfowl as hosts for influenza viruses that may contribute to human infections, we evaluated the effect of consumption of low doses of OC on development of oseltamivir-resistant influenza virus mutants in mallard ducks (Anas platyrhynchos) infected with two different low-pathogenic (LP) H5N2 avian influenza viruses (AIV). We detected development of virus variants carrying a known molecular marker of oseltamivir resistance (neuraminidase E119V) in 4 out of 6 mallards infected with A/Mallard/Minnesota/182742/1998 (H5N2) and exposed to 1,000 ng/liter OC. The mutation first appeared as a minor population on days 5 to 6 and was the dominant genotype on days 6 to 8. Oseltamivir-resistant mutations were not detected in virus from ducks not exposed to the drug or in ducks infected with a second strain of virus and similarly exposed to OC. Virus isolates carrying the E119V mutation displayed in vitro replication kinetics similar to those of the wild-type virus, but in vivo, the E119V virus rapidly reverted back to wild type in the absence of OC, and only the wild-type parental strain was transmitted to contact ducks. These results indicate that consumption by wild waterfowl of OC in drinking water may promote selection of the E119V resistance mutation in some strains of H5N2 AIV that could contribute to viruses infecting human populations.
authors: Department of Microbiology, Colorado State University, Fort Collins, Colorado, USA.
authors: Jenna E
authors: JE
authors: Achenbach
authors: Richard A
authors: RA
authors: Bowen
mesh_terms: D000818:Animals; D000998:Antiviral Agents / Q000097:blood / Q000493:pharmacokinetics / Q000494:pharmacology*; D024882:Drug Resistance, Viral / Q000187:drug effects; D004372:Ducks / Q000821:virology*; D004785:Environmental Pollutants / Q000097:blood / Q000493:pharmacokinetics / Q000494:pharmacology*; D053125:Influenza A Virus, H5N2 Subtype / Q000187:drug effects* / Q000201:enzymology / Q000235:genetics; D005585:Influenza in Birds / Q000635:transmission / Q000821:virology*; D009154:Mutation; D009439:Neuraminidase / Q000235:genetics* / Q000378:metabolism; D053139:Oseltamivir / Q000031:analogs & derivatives* / Q000097:blood / Q000493:pharmacokinetics / Q000494:pharmacology; D019562:Viral Load; D014764:Viral Proteins / Q000235:genetics* / Q000378:metabolism; D014779:Virus Replication
chemical_list: D000998:Antiviral Agents; D004785:Environmental Pollutants; D014764:Viral Proteins; D053139:Oseltamivir; D009439:Neuraminidase; C535162:oseltamivir carboxylate